Back to Scientific publications

B02-conjugates-for-mass-spectrometry-imaging-bioorthogonal

B02-conjugates-for-mass-spectrometry-imaging-bioorthogonal

Isabelle Fournier, Alexandre Goossen, Cédric Lion, Michel Salzet, Christophe Biot, Franck Rodet


WO 2025/242913 A1
https://patents.google.com/patent/WO2025242913A1/en

Abstract

Companion application to WO 2025/242912, filed the same day from the same priority. It claims a longer conjugate architecture, (A–U–L1–V–B–W–L2–X–C–Y–L3–Z–)nD, which inserts an additional linker C bearing a triazole or a diazine moiety — a bioorthogonal, click-chemistry ligation point — between the cleavable unit and the targeting entity.

The two filings protect two distinct chemistries serving the same goal: multiplexed, probe-based mass spectrometry imaging.

Patent family

Publication numberOfficeKindPublished
WO 2025/242913 A1WIPO — PCT/EP2025/064396Application2025-11-27
  • Priority date — 23 May 2024
  • Filing date — 23 May 2025
  • Status — Pending (PCT)
  • Applicants — Inserm, Université de Lille, CHU de Lille, CNRS
  • Research axis — Targeted imaging — mass-tag probes

Context

The presence of Cédric Lion and Christophe Biot among the inventors points to the chemistry at work here: the triazole or diazine motif is the signature of a click ligation between probe and target. The published abstract is generic, so the claims are the document to read.

Abstract as published

The present invention pertains to the provision of conjugates for the detection of target molecules using mass spectrometry imaging (MSI).